Recent Advances in Porphyrin-Based Covalent Organic Frameworks for Synergistic Photodynamic and Photothermal Therapy
Pharmaceutics · 22.12.2024 · 16 (12) · 1625
DOI: 10.3390/pharmaceutics16121625 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 22.12.2024. Verfasst von Cheng Qi und 5 weiteren Autor:innen. Beteiligte Einrichtung: The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang 212300, China. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Porphyrin’s excellent biocompatibility and modifiability make it a widely studied photoactive material. However, its large π-bond conjugated structure leads to aggregation and precipitation in physiological solutions, limiting the biomedical applications of porphyrin-based photoactive materials. It has been demonstrated through research that fabricating porphyrin molecules into nanoscale covalent organic frameworks (COFs) structures can circumvent issues such as poor dispersibility resulting from hydrophobicity, thereby significantly augmenting the photoactivity of porphyrin materials. Porphyrin-based COF materials can exert combined photodynamic and photothermal effects, circumventing the limitations of photodynamic therapy (PDT) due to hypoxia and issues in photothermal therapy (PTT) from heat shock proteins or the adverse impact of excessive heat on the protein activity of normal tissue. Furthermore, the porous structure of porphyrin COFs facilitates the circulation of oxygen molecules and reactive oxygen species and promotes sufficient contact with the lesion site for therapeutic functions. This review covers recent progress regarding porphyrin-based COFs in treating malignant tumors and venous thrombosis and for antibacterial and anti-inflammatory uses via combined PDT and PTT. By summarizing relevant design strategies, ranging from molecular design to functional application, this review provides a reference basis for the enhanced phototherapy application of porphyrin-based COFs as photoactive materials. This review aims to offer valuable insights for more effective biomedical applications of porphyrin-based COFs through the synthesis of existing experimental data, thereby paving the way for their future preclinical utilization.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang 212300, China.
- School of Pharmacy, Nantong University, Nantong 226001, China.
ORCID-Profile: Weiqi Wang, Xiaohua Zheng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qi, C., Chen, J., Qu, Y., Luo, X., Wang, W., & Zheng, X. (2024). Recent Advances in Porphyrin-Based Covalent Organic Frameworks for Synergistic Photodynamic and Photothermal Therapy. Pharmaceutics, 16(12), 1625. https://doi.org/10.3390/pharmaceutics16121625
Vancouver
Qi C, Chen J, Qu Y, Luo X, Wang W, Zheng X. Recent Advances in Porphyrin-Based Covalent Organic Frameworks for Synergistic Photodynamic and Photothermal Therapy. Pharmaceutics. 2024;16(12):1625. doi:10.3390/pharmaceutics16121625
BibTeX
@article{Qi2024,
author = {Qi, Cheng and Chen, Jiayi and Qu, Yijie and Luo, Xuanxuan and Wang, Weiqi and Zheng, Xiaohua},
title = {Recent Advances in Porphyrin-Based Covalent Organic Frameworks for Synergistic Photodynamic and Photothermal Therapy},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {12},
pages = {1625},
doi = {10.3390/pharmaceutics16121625}
}
EUVIMED